Gent, Belgium · Founded 2020 · Privately Held (backing)
Developer of monoclonal antibodies designed to bring to the market cost-effective services that ultimately benefit animals, producers, and consumers. Animab is based in Gent, Belgium and was founded in 2020. Its last reported valuation was $16 million in Nov 2022. It has raised $25.4 million.
Last reported valuation
$16.0M
Oct 2026
Priced at
—
Total raised
$25.4M
Last round
—
How much has Animab raised?
$25.4Macross 0 recorded rounds
Free account
More of Animab with a free account
·Watch Animab: the Monday email on marks, rounds and moves